Your browser doesn't support javascript.
loading
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients.
Chapuis, Nicolas; Ibrahimi, Nusaibah; Belmondo, Thibaut; Goulvestre, Claire; Berger, Anne-Emmanuelle; Mariaggi, Alice-Andrée; Andrieu, Muriel; Chenevier-Gobeaux, Camille; Bayle, Arnaud; Campos, Lydia; Cheurfa, Cherifa; Chocron, Richard; Diehl, Jean-Luc; Doumenc, Benoît; Duchemin, Jérôme; Duprat, Manon; François, Fabien; Gendron, Nicolas; Mirault, Tristant; Pène, Frédéric; Philippe, Aurélien; Pommeret, Fanny; Sanchez, Olivier; Smadja, David M; Szwebel, Tali-Anne; Silvin, Aymeric; Ginhoux, Florent; Lacroix, Ludovic; Jules-Clément, Gérôme; Rapeteramana, Sarobidy; Mavier, Colette; Steller, Laura; Perniconi, Barbara; André, Fabrice; Drubay, Damien; Fontenay, Michaela; Hüe, Sophie; Paul, Stéphane; Solary, Eric.
Affiliation
  • Chapuis N; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France; Université de Paris, Institut Cochin, CNRS UMR8104, INSERM U1016, Paris, France.
  • Ibrahimi N; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Center, Villejuif, France; Université Paris-Saclay, INSERM U1018, Gustave Roussy Cancer Center, Villejuif, France.
  • Belmondo T; Laboratory of Immunology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Créteil, France.
  • Goulvestre C; Laboratory of Immunology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.
  • Berger AE; Department of Immunology, University Hospital of Saint Etienne, CIC1408, GIMAP EA3064, Saint Etienne, France.
  • Mariaggi AA; Université de Paris, Institut Cochin, CNRS UMR8104, INSERM U1016, Paris, France; Assistance Publique-Hôpitaux de Paris, Laboratory of Virology, Cochin hospital, Paris, France.
  • Andrieu M; Université de Paris, Institut Cochin, CNRS UMR8104, INSERM U1016, Paris, France.
  • Chenevier-Gobeaux C; Department of automated biological diagnosis, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.
  • Bayle A; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Center, Villejuif, France; Université Paris-Saclay, INSERM U1018, Gustave Roussy Cancer Center, Villejuif, France; Drug Development Department, Gustave Roussy Cancer Center, Villejuif, France.
  • Campos L; Department of Hematology, University Hospital of Saint Etienne, Saint Etienne, France.
  • Cheurfa C; Department of Anesthesiology and Intensive care, Assistance Publique-Hôpitaux de Paris, Cochin hospital, Paris, France.
  • Chocron R; Department of Emergency, Assistance Publique-Hôpitaux de Paris, European Georges Pompidou Hospital, Paris, France; Paris Cardiovascular Research Center (PARCC), Université de Paris, INSERM U970, European Georges Pompidou Hospital, Paris, France.
  • Diehl JL; Medical Intensive Care Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique-Hôpitaux de Paris, Georges Pompidou European Hospital, Paris, France; Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris France.
  • Doumenc B; Department of Emergencies, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.
  • Duchemin J; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.
  • Duprat M; Department of Immunology, University Hospital of Saint Etienne, CIC1408, GIMAP EA3064, Saint Etienne, France.
  • François F; Department of Immunology, University Hospital of Saint Etienne, CIC1408, GIMAP EA3064, Saint Etienne, France.
  • Gendron N; Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris France; Department of Emergencies, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.
  • Mirault T; Paris Cardiovascular Research Center (PARCC), Université de Paris, INSERM U970, European Georges Pompidou Hospital, Paris, France.
  • Pène F; Université de Paris, Institut Cochin, CNRS UMR8104, INSERM U1016, Paris, France; Assistance Publique-Hôpitaux de Paris, Medical Intensive Care, Cochin hospital, Paris, France.
  • Philippe A; Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris France; Department of Biological Hematology, Assistance Publique-Hôpitaux de Paris, Georges Pompidou European Hospital, Paris France; Laboratory of Hematology and Biosurgical Research (Carpentier Foundation)Assistance Publ
  • Pommeret F; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France.
  • Sanchez O; Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris France; Department of Pneumology and Intensive Care, Assistance Publique-Hôpitaux de Paris, European Georges Pompidou Hospital, Paris, France.
  • Smadja DM; Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris France; Department of Biological Hematology, Assistance Publique-Hôpitaux de Paris, Georges Pompidou European Hospital, Paris France.
  • Szwebel TA; Internal Medicine Department, Assistance Publique-Hôpitaux de Paris, Cochin hospital, Paris, France.
  • Silvin A; University Paris-Saclay, INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France.
  • Ginhoux F; University Paris-Saclay, INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France.
  • Lacroix L; Department of Biopathology, Gustave Roussy Cancer Center, Villejuif, France.
  • Jules-Clément G; Gustave Roussy Cancer Center, Bioinformatics platform, Université Paris-Saclay, INSERM US23, CNRS UMS 3655, Villejuif, France.
  • Rapeteramana S; Gustave Roussy Cancer Center, Bioinformatics platform, Université Paris-Saclay, INSERM US23, CNRS UMS 3655, Villejuif, France.
  • Mavier C; Thermofisher immunodiagnostics, Dardilly, France.
  • Steller L; Thermo Fisher Scientific ImmunoDiagnostics, Phadia GmbH, Freiburg, Germany.
  • Perniconi B; CerbaXpert Alliance, Saint Ouen L'Aumone, France.
  • André F; Medical Oncology Department, Gustave Roussy Cancer Center, Villejuif, France.
  • Drubay D; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Center, Villejuif, France; Université Paris-Saclay, INSERM U1018, Gustave Roussy Cancer Center, Villejuif, France.
  • Fontenay M; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France; Université de Paris, Institut Cochin, CNRS UMR8104, INSERM U1016, Paris, France; Laboratory of Immunology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.
  • Hüe S; Laboratory of Immunology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Créteil, France.
  • Paul S; Department of Immunology, University Hospital of Saint Etienne, CIC1408, GIMAP EA3064, Saint Etienne, France.
  • Solary E; Université Paris-Saclay, INSERM U1287, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, Villejuif 94805, France; Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: eric.solary@gustaveroussy.fr.
EBioMedicine ; 80: 104077, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35644124
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukocyte L1 Antigen Complex / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukocyte L1 Antigen Complex / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article